Cardiol Therapeutics Inc.
CRDL
Price:
$1.62
Market Cap:
$184.81M
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx as a cardioprotective therapy to reduce cardiovascular and respiratory events in patients hospitalized with COVID-19, as well as to evaluate the efficacy and safety of CardiolRx in acute myocarditis. The company is also developing subcutaneous formulation of CardiolRx for the treatment of fibrosis and inflammation i...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2019-01-15
Stock Exchange
NASDAQ
Ticker
CRDL
PE Ratio
[-4.15]
ROE
[-195.07%]
Current Ratio
[2.49]
Dividend Yield
[0%]
Enterprise Value
[169.09M]
Dividend History
The ROE as of November 2024 (TTM) for Cardiol Therapeutics Inc. (CRDL) is -195.07%
According to Cardiol Therapeutics Inc.’s latest financial reports and current stock price. The company's current ROE is -195.07%. This represents a change of 228.23% compared to the average of -59.43% of the last 4 quarters.
Cardiol Therapeutics Inc. (CRDL) Historical ROE (quarterly & annually)
How has CRDL ROE performed in the past?
The mean historical ROE of Cardiol Therapeutics Inc. over the last ten years is -82.67%. The current -195.07% ROE has changed 135.96% with respect to the historical average. Over the past ten years (40 quarters), CRDL's ROE was at its highest in in the September 2018 quarter at 153.02%. The ROE was at its lowest in in the June 2018 quarter at -146.91%.
Average
-82.67%
Median
-71.36%
Minimum
-155.54%
Maximum
-41.50%
Cardiol Therapeutics Inc. (CRDL) ROE by Quarter and Year
Discovering the peaks and valleys of Cardiol Therapeutics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 68.06%
Maximum Annual ROE = -41.50%
Minimum Annual Increase = -73.32%
Minimum Annual ROE = -155.54%
| Year | ROE | Change |
|---|---|---|
| 2023 | -99.58% | 68.06% |
| 2022 | -59.25% | 42.78% |
| 2021 | -41.50% | -73.32% |
| 2020 | -155.54% | 66.77% |
| 2019 | -93.27% | 30.71% |
| 2018 | -71.36% | 22.61% |
Cardiol Therapeutics Inc. (CRDL) Average ROE
How has CRDL ROE performed in the past?
The current ROE of Cardiol Therapeutics Inc. (CRDL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-66.78%
5-year avg
-89.83%
10-year avg
-82.67%
Cardiol Therapeutics Inc. (CRDL) ROE vs. Peers
How is CRDL’s ROE compared to its peers?
Cardiol Therapeutics Inc.’s ROE is greater than Flora Growth Corp. (-342.39%), greater than ABVC BioPharma, Inc. (-98.40%), greater than Indaptus Therapeutics, Inc. (-177.27%), greater than HCW Biologics Inc. (-2516.87%), greater than PainReform Ltd. (-450.64%),
| Company | ROE | Market cap |
|---|---|---|
| -342.39% | $19.11M | |
| -98.40% | $7.12M | |
| -177.27% | $10.20M | |
| -2516.87% | $29.12M | |
| -450.64% | $1.65M |
Build a custom stock screener for Cardiol Therapeutics Inc. (CRDL) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cardiol Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Cardiol Therapeutics Inc. (CRDL) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Cardiol Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Cardiol Therapeutics Inc.'s ROE?
How is the ROE calculated for Cardiol Therapeutics Inc. (CRDL)?
What is the highest ROE for Cardiol Therapeutics Inc. (CRDL)?
What is the 3-year average ROE for Cardiol Therapeutics Inc. (CRDL)?
What is the 5-year average ROE for Cardiol Therapeutics Inc. (CRDL)?
How does the current ROE for Cardiol Therapeutics Inc. (CRDL) compare to its historical average?